Shattuck Labs STTK
NASDAQ STTK
$6.79 -0.17 (-2.44%)
As of: Sep 4, 2026 · 3:59 PM EDT

Shattuck Labs (STTK) Capital Expenditures (2019 - 2026)

Shattuck Labs (STTK) posted quarterly Capital Expenditures of $63000.0 for Q1 2026, down 11.27% quarter-over-quarter from $71000.0 in Q3 2025.

Analysis

Shattuck Labs (STTK) Capital Expenditures (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has reported Capital Expenditures for 8 consecutive years, with $63000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Capital Expenditures changed N/A year-over-year to $63000.0; the TTM figure through Mar 2026 stood at $134000.0 (up 127.12% YoY), while the FY2025 annual figure was $71000.0, up 20.34% from the prior year.
  • Capital Expenditures fell to $63000.0 in Q1 2026 per STTK's latest filing, from $71000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $10.7 million in Q3 2022 and bottomed at -$2.3 million in Q2 2022.
  • Historically, Capital Expenditures has averaged $1.0 million across 5 years, with a median of $67000.0 in 2025.
  • Annual changes were most pronounced in 2022 — Capital Expenditures tumbled 1576.92% — and 2024, when it jumped 121.05%.
  • Shattuck Labs' Capital Expenditures stood at $693000.0 in 2022, then slumped by 97.55% to $17000.0 in 2023, then jumped by 147.06% to $42000.0 in 2024, then surged by 69.05% to $71000.0 in 2025, then retreated by 11.27% to $63000.0 in 2026.
  • Business Quant data shows STTK's Capital Expenditures at $63000.0 in Q1 2026, $71000.0 in Q3 2025, and $42000.0 in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Shattuck Labs 885.09 Mn 885.09 Mn - 78,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 78,000.00
Mar 31, 2026 63,000.00
Sep 30, 2025 71,000.00
Sep 30, 2024 42,000.00
Jun 30, 2024 17,000.00
Dec 31, 2023 17,000.00
Sep 30, 2023 19,000.00
Jun 30, 2023 216,000.00
Mar 31, 2023 155,000.00
Dec 31, 2022 693,000.00
Sep 30, 2022 750,000.00
Jun 30, 2022 7.68 Mn
Mar 31, 2022 2.49 Mn
Dec 31, 2021 1.99 Mn
Sep 30, 2021 964,000.00
Jun 30, 2021 2.33 Mn
Mar 31, 2021 2.64 Mn
Dec 31, 2020 201,000.00
Sep 30, 2020 99,000.00
Jun 30, 2020 319,000.00